Delta-Fly Pharma, Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc. (ＤｅｌｔａーＦｌｙ Ｐｈａｒｍａ株式会社, 4598), Pharmaceutical. A board of 9 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YJOM, filed 2026-06-24. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2022-03-31 | 0.3 | −1.0 | 1.3 | −178.58 | — | 12 |
| 2023-03-31 | −1.3 | −1.3 | 0.9 | −234.51 | — | 11 |
| 2024-03-31 | −1.4 | −1.4 | 1.5 | −198.78 | — | 13 |
| 2025-03-31 | −1.7 | −1.7 | 0.4 | −195.58 | — | 13 |
| 2026-03-31 | −1.6 | −1.6 | 0.2 | −140.45 | — | 12 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown